Sartorius Stedim Biotech revenue for the last year amounted to 3.06 B USD, the most of which — 3.06 B USD — came from its highest performing source at the moment, Biopharmaceuticals, the year earlier bringing 3.74 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Sartorius Stedim Biotech 1.07 B USD, and the year before that — 1.30 B USD.